Despite promising strategies for treating neurodegenerative disease - e.g., engineered proteins, antibody-based "vaccines,"
and RNA interference - delivery of these agents to the nervous system remains a challenge.
This initiative supports the development of delivery tools, including new viral vectors and standardized cell lines.
Enables established investigators to acquire interdisciplinary perspectives and skills in neurodegeneration research through
short-term mentorship and training, typically during an academic sabbatical.